Oliver Boucher

Oliver Boucher has a successful record of transactions on both the buy-side (M&A and in-licensing) and sell-side (creating and managing start-ups and executing Board level strategic transactions) of the B2B market in the life sciences, including the pharmaceutical, biotech and diagnostics industries and, since 2017, animal health.

Boucher also has significant experience in fund-raising, both dilutive and non-dilutive. Before Zoetis, Oliver held senior commercial and business roles in a succession of biotech companies after having gained executive-level experience for seven years as a director of business development at GSK. Before joining industry, Oliver Boucher was a patent attorney in London, Montreal and Paris.

Boucher received an MA in genetics and molecular biology from Cambridge University and earned an MBA from INSEAD Business School. He joined the Global Business Development team at Zoetis in 2017.

Areas of Expertise

• M&A and in-licensing
• Creating and managing start-ups
• Executing Board level strategic transactions
• Pharma
• Biotech
• Diagnostics
• Animal Health